CL2020002200A1 - Nuevos vectores del virus adeno-asociado (aav), vectores que tienen desaminación de capside reducida y sus usos. - Google Patents
Nuevos vectores del virus adeno-asociado (aav), vectores que tienen desaminación de capside reducida y sus usos.Info
- Publication number
- CL2020002200A1 CL2020002200A1 CL2020002200A CL2020002200A CL2020002200A1 CL 2020002200 A1 CL2020002200 A1 CL 2020002200A1 CL 2020002200 A CL2020002200 A CL 2020002200A CL 2020002200 A CL2020002200 A CL 2020002200A CL 2020002200 A1 CL2020002200 A1 CL 2020002200A1
- Authority
- CL
- Chile
- Prior art keywords
- vectors
- associated virus
- aav
- capsid
- adeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635964P | 2018-02-27 | 2018-02-27 | |
| US201862677471P | 2018-05-29 | 2018-05-29 | |
| US201862667585P | 2018-05-29 | 2018-05-29 | |
| US201862703670P | 2018-07-26 | 2018-07-26 | |
| US201862722382P | 2018-08-24 | 2018-08-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2020002200A1 true CL2020002200A1 (es) | 2021-01-29 |
Family
ID=67805569
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2020002200A CL2020002200A1 (es) | 2018-02-27 | 2020-08-26 | Nuevos vectores del virus adeno-asociado (aav), vectores que tienen desaminación de capside reducida y sus usos. |
| CL2022003757A CL2022003757A1 (es) | 2018-02-27 | 2022-12-26 | Vectores de aav que tienen una desamidación reducida de la cápside y sus usos (divisional solic 202002200). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2022003757A CL2022003757A1 (es) | 2018-02-27 | 2022-12-26 | Vectores de aav que tienen una desamidación reducida de la cápside y sus usos (divisional solic 202002200). |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200407750A1 (enExample) |
| EP (1) | EP3758724A4 (enExample) |
| JP (3) | JP2021516046A (enExample) |
| KR (1) | KR20210010434A (enExample) |
| CN (2) | CN119842635A (enExample) |
| AU (1) | AU2019227726B2 (enExample) |
| BR (1) | BR112020017348A2 (enExample) |
| CA (1) | CA3091806A1 (enExample) |
| CL (2) | CL2020002200A1 (enExample) |
| IL (1) | IL276859B2 (enExample) |
| MX (1) | MX2020008933A (enExample) |
| SG (1) | SG11202008182TA (enExample) |
| WO (1) | WO2019168961A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2865487T3 (es) | 2015-09-28 | 2021-10-15 | Univ North Carolina Chapel Hill | Métodos y composiciones para vectores virales que evaden los anticuerpos |
| JP2021519581A (ja) | 2018-04-03 | 2021-08-12 | ストライドバイオ，インコーポレイテッド | 抗体を回避するウイルスベクター |
| SG11202009452WA (en) | 2018-04-03 | 2020-10-29 | Stridebio Inc | Antibody-evading virus vectors |
| AU2019247191A1 (en) | 2018-04-03 | 2020-10-15 | Ginkgo Bioworks, Inc. | Virus vectors for targeting ophthalmic tissues |
| WO2020072451A1 (en) | 2018-10-01 | 2020-04-09 | Ultragenyx Pharmaceutical Inc. | Gene therapy for treating propionic acidemia |
| AR118465A1 (es) | 2019-03-21 | 2021-10-06 | Stridebio Inc | Vectores de virus adenoasociados recombinantes |
| JP2022550435A (ja) | 2019-10-04 | 2022-12-01 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | 組換えａａｖの改善された治療的使用のための方法 |
| CA3157700A1 (en) | 2019-10-17 | 2021-04-22 | Stridebio, Inc. | Adeno-associated viral vectors for treatment of niemann-pick disease type c |
| JP2022552892A (ja) * | 2019-10-21 | 2022-12-20 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 改善された産生収率および肝臓向性を有するａａｖ３ｂ変異体 |
| CA3165911A1 (en) * | 2020-01-03 | 2021-07-08 | Sarepta Therapeutics, Inc. | Methods for analyzing aav capsid proteins |
| IL294781A (en) * | 2020-02-14 | 2022-09-01 | Ultragenyx Pharmaceutical Inc | Gene therapy for treating cdkl5 deficiency disorder |
| JP2023520402A (ja) | 2020-03-31 | 2023-05-17 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | プロピオン酸血症を処置するための遺伝子治療 |
| BR112022021762A2 (pt) * | 2020-04-27 | 2023-01-17 | Univ Pennsylvania | Composições úteis em tratamento de distúrbio de deficiência de cdkl5 (cdd) |
| US20230220069A1 (en) | 2020-06-17 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of gene therapy patients |
| JP2023534037A (ja) | 2020-07-13 | 2023-08-07 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | シャルコー・マリー・トゥース病の治療に有用な組成物 |
| CA3189878A1 (en) | 2020-08-19 | 2022-02-24 | Colin O'BANION | Adeno-associated virus vectors for treatment of rett syndrome |
| CA3195553A1 (en) * | 2020-10-18 | 2022-04-21 | Qiang Wang | Improved adeno-associated virus (aav) vector and uses therefor |
| TW202233844A (zh) * | 2020-10-29 | 2022-09-01 | 賓州大學委員會 | Aav衣殼及含有其之組成物 |
| JP2023551903A (ja) | 2020-12-01 | 2023-12-13 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 組織特異的標的化モチーフを有する新規組成物及びそれを含有する組成物 |
| BR112023015303A2 (pt) | 2021-02-01 | 2023-11-14 | Regenxbio Inc | Método para tratar doença cln2 devido a deficiência de tpp1 em um sujeito |
| KR20230170022A (ko) | 2021-04-12 | 2023-12-18 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 척수 및 연수 근위축증(sbma) 치료에 유용한 조성물 |
| MX2023012513A (es) | 2021-04-23 | 2023-12-15 | Univ Pennsylvania | Nuevas composiciones con motivos selectivos para el cerebro y composiciones que las contienen. |
| AU2022423978A1 (en) * | 2021-12-28 | 2024-07-18 | Chengdu Origen Biotechnology Co., Ltd. | Modified aav capsid protein and use thereof |
| US20250177495A1 (en) | 2022-01-10 | 2025-06-05 | The Trustees Of The University Of Pennsylvania | Compositions useful in treatment of metachromatic leukodystrophy |
| WO2023133574A1 (en) | 2022-01-10 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Compositions and methods useful for treatment of c9orf72-mediated disorders |
| US20250144243A1 (en) | 2022-01-25 | 2025-05-08 | The Trustees Of The University Of Pennsylvania | Aav capsids for improved heart transduction and detargeting of liver |
| TW202342740A (zh) | 2022-03-07 | 2023-11-01 | 美商奧崔基尼克斯製藥公司 | 改良的批量aav生產系統和方法 |
| WO2023196892A1 (en) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors |
| CN115011601B (zh) * | 2022-06-27 | 2023-07-21 | 山东大学齐鲁医院 | 一种干扰JUND表达的shRNA、重组腺相关病毒载体及其应用 |
| WO2024015966A2 (en) * | 2022-07-15 | 2024-01-18 | The Trustees Of The University Of Pennsylvania | Recombinant aav having aav clade d and clade e capsids and compositions containing same |
| CN115554418B (zh) | 2022-11-22 | 2023-04-14 | 四川至善唯新生物科技有限公司 | 一种重组腺相关病毒载体的药物组合物及其用途 |
| WO2024130070A2 (en) | 2022-12-17 | 2024-06-20 | The Trustees Of The University Of Pennsylvania | Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof |
| WO2024130067A2 (en) | 2022-12-17 | 2024-06-20 | The Trustees Of The University Of Pennsylvania | Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same |
| TW202432191A (zh) * | 2022-12-23 | 2024-08-16 | 美商星火治療公司 | 腺相關病毒調配物 |
| CN121079310A (zh) * | 2023-05-03 | 2025-12-05 | 沃雅戈治疗公司 | 用于治疗与cdkl5缺乏相关的病症的组合物及方法 |
| CN121127597A (zh) * | 2023-05-03 | 2025-12-12 | 沃雅戈治疗公司 | 用于治疗与葡糖苷酰鞘氨醇酶β1缺陷相关的病症的组合物及方法 |
| WO2025007046A1 (en) | 2023-06-29 | 2025-01-02 | The Trustees Of The University Of Pennsylvania | Mutant aav with central nervous system targeting motifs and compositions containing same |
| WO2025102034A1 (en) | 2023-11-10 | 2025-05-15 | The Trustees Of The University Of Pennsylvania | Gene therapy for barth syndrome |
| WO2025106661A1 (en) | 2023-11-14 | 2025-05-22 | The Trustees Of The University Of Pennsylvania | Compositions with cardiac and skeletal musclespecific targeting motifs and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2874298T3 (es) * | 2003-09-30 | 2021-11-04 | Univ Pennsylvania | Clados de virus adenoasociados (AAV), secuencias, vectores que contienen el mismo, y usos de los mismos |
| ES2428218T3 (es) * | 2005-04-07 | 2013-11-06 | The Trustees Of The University Of Pennsylvania | Cápsides de AAV rh48 modificadas, composiciones que las contienen y usos de las mismas |
| ES2862912T3 (es) * | 2012-04-18 | 2021-10-08 | Childrens Hospital Philadelphia | Composición y procedimientos para la transferencia genética de alta eficiencia utilizando variantes de cápside de VAA |
| MX2016001044A (es) * | 2013-07-22 | 2016-09-09 | The Children's Hospital Of Philadelphia | Aav variante y composiciones, metodos y usos para transferencia genica a celulas, organos y tejidos. |
| WO2017100674A1 (en) * | 2015-12-11 | 2017-06-15 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav1 |
| AU2017248656B2 (en) * | 2016-04-15 | 2023-07-27 | The Trustees Of The University Of Pennsylvania | Novel AAV8 mutant capsids and compositions containing same |
| SG10201913002QA (en) * | 2016-08-15 | 2020-03-30 | Genzyme Corp | Methods for detecting aav |
| WO2018160582A1 (en) * | 2017-02-28 | 2018-09-07 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
-
2019
- 2019-02-27 EP EP19760264.2A patent/EP3758724A4/en active Pending
- 2019-02-27 US US16/975,541 patent/US20200407750A1/en active Pending
- 2019-02-27 WO PCT/US2019/019804 patent/WO2019168961A1/en not_active Ceased
- 2019-02-27 CA CA3091806A patent/CA3091806A1/en active Pending
- 2019-02-27 JP JP2020545160A patent/JP2021516046A/ja active Pending
- 2019-02-27 CN CN202411591073.2A patent/CN119842635A/zh active Pending
- 2019-02-27 CN CN201980028806.2A patent/CN112352050A/zh active Pending
- 2019-02-27 KR KR1020207027457A patent/KR20210010434A/ko not_active Ceased
- 2019-02-27 AU AU2019227726A patent/AU2019227726B2/en active Active
- 2019-02-27 BR BR112020017348-7A patent/BR112020017348A2/pt unknown
- 2019-02-27 SG SG11202008182TA patent/SG11202008182TA/en unknown
- 2019-02-27 MX MX2020008933A patent/MX2020008933A/es unknown
-
2020
- 2020-08-23 IL IL276859A patent/IL276859B2/en unknown
- 2020-08-26 CL CL2020002200A patent/CL2020002200A1/es unknown
-
2022
- 2022-12-26 CL CL2022003757A patent/CL2022003757A1/es unknown
-
2023
- 2023-08-14 JP JP2023131761A patent/JP2023159235A/ja active Pending
-
2024
- 2024-01-18 JP JP2024005924A patent/JP2024041967A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200407750A1 (en) | 2020-12-31 |
| MX2020008933A (es) | 2021-01-15 |
| CN112352050A (zh) | 2021-02-09 |
| AU2019227726B2 (en) | 2025-09-04 |
| EP3758724A4 (en) | 2022-07-06 |
| BR112020017348A2 (pt) | 2020-12-29 |
| AU2019227726A1 (en) | 2020-09-10 |
| IL276859A (en) | 2020-10-29 |
| CL2022003757A1 (es) | 2023-05-19 |
| JP2023159235A (ja) | 2023-10-31 |
| IL276859B1 (en) | 2025-08-01 |
| JP2024041967A (ja) | 2024-03-27 |
| SG11202008182TA (en) | 2020-09-29 |
| KR20210010434A (ko) | 2021-01-27 |
| CN119842635A (zh) | 2025-04-18 |
| EP3758724A1 (en) | 2021-01-06 |
| IL276859B2 (en) | 2025-12-01 |
| WO2019168961A1 (en) | 2019-09-06 |
| JP2021516046A (ja) | 2021-07-01 |
| CA3091806A1 (en) | 2019-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020002200A1 (es) | Nuevos vectores del virus adeno-asociado (aav), vectores que tienen desaminación de capside reducida y sus usos. | |
| CL2020002201A1 (es) | Novedosos vectores de virus adenoasociado (aav), vectores de aav que tienen una desamidación reducida de la cápside y usos de estos. | |
| CL2019002474A1 (es) | Vector clado f de virus adeno-asociado (vaa) y usos relacionados. | |
| CO2021013878A2 (es) | Vectores de virus adenoasociado recombinantes | |
| MX2019009720A (es) | Metodos y composiciones para la transferencia de genes a traves de la vasculatura. | |
| CO2018012082A2 (es) | Administración de vectores del virus adenoasociado de β-sarcoglicano y microarn-29 y el tratamiento de la distrofia muscular | |
| CO2020004738A2 (es) | Variantes de cápsides de virus adenoasociados y métodos de uso de estas | |
| CL2021002236A1 (es) | Inserción de vectores de virus adeno-asociados de b-sarcoglicano y el tratamiento de distrofia muscular | |
| CL2020001360A1 (es) | Cápsides variantes de virus adenoasociados y su uso para inhibir la angiogénesis. | |
| CO2021008120A2 (es) | Vectores virales recombinantes y ácidos nucleicos para producirlos | |
| PE20250736A1 (es) | Terapia genica para tratar la hemofilia a | |
| AR118734A1 (es) | Formulaciones y métodos de vectores de virus adenoasociados | |
| MX2020010466A (es) | Vectores de virus que evitan anticuerpos. | |
| CL2020000295A1 (es) | Métodos de terapia génica del factor viii (fviii) | |
| PE20190129A1 (es) | Capsides variantes de virus adenoasociados y metodos de uso de estas | |
| PE20231949A1 (es) | VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA | |
| EA201791936A8 (ru) | Рекомбинантные конструкции glut1 аденоассоциированного вирусного вектора и способы восстановления экспрессии glut1 на их основе | |
| AR124119A2 (es) | Partículas virales modificadas y usos de estas | |
| MX2018007234A (es) | Vectores virales adenoasociados utiles en el tratamiento de atrofia muscular espinal. | |
| MX2021013420A (es) | Composiciones utiles en el tratamiento de leucodistrofia metacromatica. | |
| CL2023001650A1 (es) | Tratamiento de la enfermedad de danon | |
| EA202092015A1 (ru) | Новые векторы на основе аденоассоциированного вируса (aav), векторы aav, со сниженным дезамидированием капсида, а также их применение | |
| EA202092046A1 (ru) | Новые векторы на основе аденоассоциированного вируса (aav), векторы aav, со сниженным дезамидированием капсида, а также их применения | |
| CL2022002498A1 (es) | Vectores de virus adenoasociado que tienen una desamidación reducida de la cápside (divisional solic 202002201). | |
| AR108687A1 (es) | Terapia génica para el tratamiento de hemofilia a |